Protagonist Therapeutics Inc Stock Forecast
Protagonist Therapeutics Inc stock downgraded from Strong Buy Candidate to Hold/Accumulate after Tuesday trading session.
(Updated on Jul 02, 2024)
The Protagonist Therapeutics Inc stock price fell by -1.73% on the last day (Tuesday, 2nd Jul 2024) from $35.20 to $34.59. During the last trading day the stock fluctuated 4.63% from a day low at $34.31 to a day high of $35.90. The price has risen in 6 of the last 10 days and is up by 6.53% over the past 2 weeks. Volume has increased on the last day by 8 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 10 million shares were bought and sold for approximately $334.90 million.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $35.34 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 31.68% during the next 3 months and, with a 90% probability hold a price between $40.46 and $46.53 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PTGX Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, July 01, 2024, and so far it has fallen -1.73%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Protagonist Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $33.11 and $31.82. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Protagonist Therapeutics Inc stock
Protagonist Therapeutics Inc finds support from accumulated volume at $34.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.59 between high and low, or 4.63%. For the last week, the stock has had daily average volatility of 4.25%.
Our recommended stop-loss: $33.56 (-2.99%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)
Trading Expectations (PTGX) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Protagonist Therapeutics Inc to open at $34.93, and during the day (based on 14 day Average True Range), to move between $32.98 and $36.20, which gives a possible trading interval of +/-$1.61 (+/-4.65%) up or down from last closing price. If Protagonist Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 9.31% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $34.65 (0.17%) than the support at $34.03 (1.62%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Protagonist Therapeutics Inc stock A Buy?
Protagonist Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.
Current score: 0.703 Hold/Accumulate Downgraded
Predicted Opening Price for Protagonist Therapeutics Inc of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $34.93 ( 0.99%) | $34.59 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PTGX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 36.52 | 5.59% |
| R2 | 35.92 | 3.83% |
| R1 | 35.54 | 2.75% |
| Price | 34.59 | |
| S1 | 34.33 | -0.763% |
| S2 | 33.95 | -1.85% |
| S3 | 33.34 | -3.60% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 35.20 | 1.76% |
| R2 | 34.80 | 0.607% |
| R1 | 34.65 | 0.173% |
| Price | 34.59 | |
| S1 | 34.03 | -1.62% |
| S2 | 32.26 | -6.74% |
| S3 | 31.71 | -8.33% |
FAQ
Click here for our free guide on how to buy Protagonist Therapeutics Inc Stock.
